ProLynx Announces Publication of Its Once Monthly Semaglutide in the Proceedings of the National Academy of Sciences
Single injection of ProLynx long-acting semaglutide produced 20% weight loss in diet-induced obese mice, which is comparable to multiple semaglutide injections over the same period SAN FRANCISCO, Dec. 2, 2024 /PRNewswire/ — ProLynx Inc., a biotechnology company developing proprietary systems t
AGFA HealthCare and Rad AI Announce Strategic Collaboration to Enhance Radiology Workflows
Collaboration addresses longstanding inefficiencies in radiology workflow, as well as reducing burnout and empowering radiologists to focus on what truly matters – “staying in the flow”. CHICAGO, Dec. 2, 2024 /PRNewswire/ — AGFA HealthCare and Rad AI are announcing a strategi
HyBryte™ Clinical Results Demonstrate Continued Improvement Post-Treatment
Significant Efficacy against Plaque Lesions Also Demonstrated with HyBryte™ PRINCETON, N.J., Dec. 2, 2024 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases
VersaBank to Report Fourth Quarter and Fiscal 2024 Year End Results Monday, December 9, 2024 at 7:00 a.m. ET
LONDON, ON, Dec. 2, 2024 /PRNewswire/ – VersaBank (“VersaBank” or the “Bank”) (TSX: VBNK) (NASDAQ: VBNK) will report its fourth quarter and fiscal 2024 year-end financial results and host a conference call to discuss those results on Monday, December 9, 2024. The confer
The Winter issue of World Finance magazine has been published and it is packed with insightful articles and expert analysis covering a wide spectrum of global financial topics
News provided by World News Media LONDON, Dec. 2, 2024 /PRNewswire/ — The front cover of the latest World Finance magazine (Winter 2024–25) features Claudia Sheinbaum, the newly elected President of Mexico. The former environmental scientist, mayor of Mexico City and Nobel Prize winner, is
FAIR PLAY MENARINI – THE CHAMPIONS TELL THEIR STORIES: TALES OF SPORT AND LIFE TRIUMPH AT THE TALK SHOW
FLORENCE, Italy, Dec. 2, 2024 /PRNewswire/ — Thoughts, anecdotes and unexpected backstories providing an insight into sport. It was an emotion-packed evening for the talk show Fair Play Menarini – The Champions Tell their Stories. Fair play, Olympic spirit, and respect served as the unifyi
" title="Revolutionizing Spine Surgery: Manipal Hospitals Hosts “Roboticon 2024”
BENGALURU, India, Dec. 2, 2024 /PRNewswire/ — Manipal Hospital Old Airport Road, Bengaluru hosted Roboticon 2024, an extraordinary conference on robotic spine surgery. The two-day event, which commenced on 30th November 2024 and concluded on 1st December 2024, was one of the most unique and gr
AT FAULT NOW OPEN FOR PLAY AND DINING
Premier eatertainment facility offers unique space for pickleball and socializing DALLAS, Dec. 2, 2024 /PRNewswire/ — Dallas-based At Fault, the elevated pickleball and social hub, is now open at 2330 Jett Street in Farmers Branch, combining the thrill of pickleball with scratch-made dining i
AtkinsRéalis announces AMEA President Departure
MONTREAL, Dec. 2, 2024 /CNW/ – AtkinsRéalis Group Inc. (TSX: ATRL), a world-class engineering services and nuclear company with offices around the world, announces that, effective December 31st, Christine Healy is stepping down as President for Asia, Middle East and Australia (AMEA) to pursu
Endo Launches ADRENALIN® Ready-to-Use Premixed Bag, the First and Only FDA-Approved, Manufacturer-Prepared Epinephrine Premixed IV Bag
MALVERN, Pa., Dec. 2, 2024 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) announced today the launch of its ADRENALIN® (epinephrine in 0.9% sodium chloride injection) ready-to-use premixed bag, the first and only FDA-approved, manufacturer-prepared epinephrine premixed intravenous (IV) bag. “T
